Align 3-phosphoshikimate 1-carboxyvinyltransferase (EC 2.5.1.19) (characterized)
to candidate 6937579 Sama_1734 3-phosphoshikimate 1-carboxyvinyltransferase (RefSeq)
Query= BRENDA::Q9KRB0 (426 letters) >FitnessBrowser__SB2B:6937579 Length = 428 Score = 606 bits (1563), Expect = e-178 Identities = 299/426 (70%), Positives = 348/426 (81%) Query: 1 MESLTLQPIELISGEVNLPGSKSVSNRALLLAALASGTTRLTNLLDSDDIRHMLNALTKL 60 M+ L L+P+ ++G VN+PGSKS+SNRALLLA LASG T L NLLDSDDIRHMLNAL L Sbjct: 1 MDQLRLEPVSRVNGVVNIPGSKSISNRALLLATLASGETTLVNLLDSDDIRHMLNALKSL 60 Query: 61 GVNYRLSADKTTCEVEGLGQAFHTTQPLELFLGNAGTAMRPLAAALCLGQGDYVLTGEPR 120 GVN+ LS DKT C + GLG T + ELFLGNAGTAMRPL AAL LG G++ LTGEPR Sbjct: 61 GVNFTLSDDKTVCTLNGLGGPIQTDKAFELFLGNAGTAMRPLCAALTLGTGEFTLTGEPR 120 Query: 121 MKERPIGHLVDALRQAGAQIEYLEQENFPPLRIQGTGLQAGTVTIDGSISSQFLTAFLMS 180 M+ERPIG LVDALRQ GA I YL+ + FPPL I TGL G V IDGS+SSQFLTA LM Sbjct: 121 MEERPIGDLVDALRQLGADIRYLKNDGFPPLTINATGLAGGVVEIDGSLSSQFLTALLMV 180 Query: 181 APLAQGKVTIKIVGELVSKPYIDITLHIMEQFGVQVINHDYQEFVIPAGQSYVSPGQFLV 240 APLA+G VTI + GELVSKPYIDITL +M +FGV V+N +YQ F I +GQ YVSPG+ LV Sbjct: 181 APLAKGAVTIAVKGELVSKPYIDITLDLMAKFGVTVVNDNYQRFEIASGQHYVSPGKVLV 240 Query: 241 EGDASSASYFLAAAAIKGGEVKVTGIGKNSIQGDIQFADALEKMGAQIEWGDDYVIARRG 300 EGDASSASYFLAA AI GGEVKVTG+G+ ++QGD++FADAL MGA IEWG+DY+IAR Sbjct: 241 EGDASSASYFLAAGAIGGGEVKVTGVGRLAVQGDVKFADALAAMGADIEWGEDYIIARGS 300 Query: 301 ELNAVDLDFNHIPDAAMTIATTALFAKGTTAIRNVYNWRVKETDRLAAMATELRKVGATV 360 +L+ +D+D NHIPDAAMTIAT ALFA+GTT + N+YNWR+KETDRLAAMATELRKVGA V Sbjct: 301 KLHGIDMDMNHIPDAAMTIATAALFAEGTTRMSNIYNWRIKETDRLAAMATELRKVGAKV 360 Query: 361 EEGEDFIVITPPTKLIHAAIDTYDDHRMAMCFSLVALSDTPVTINDPKCTSKTFPDYFDK 420 EEG D+I ITPP K +HA IDTY+DHRMAMCFSL+A +D VTINDP CTSKTFPDYF++ Sbjct: 361 EEGHDYIQITPPVKPVHAEIDTYNDHRMAMCFSLLAFADCGVTINDPGCTSKTFPDYFNR 420 Query: 421 FAQLSR 426 FA L++ Sbjct: 421 FANLAK 426 Lambda K H 0.318 0.135 0.384 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 561 Number of extensions: 19 Number of successful extensions: 4 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 426 Length of database: 428 Length adjustment: 32 Effective length of query: 394 Effective length of database: 396 Effective search space: 156024 Effective search space used: 156024 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.4 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.7 bits) S2: 51 (24.3 bits)
Align candidate 6937579 Sama_1734 (3-phosphoshikimate 1-carboxyvinyltransferase (RefSeq))
to HMM TIGR01356 (aroA: 3-phosphoshikimate 1-carboxyvinyltransferase (EC 2.5.1.19))
# hmmsearch :: search profile(s) against a sequence database # HMMER 3.3.1 (Jul 2020); http://hmmer.org/ # Copyright (C) 2020 Howard Hughes Medical Institute. # Freely distributed under the BSD open source license. # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - # query HMM file: ../tmp/path.aa/TIGR01356.hmm # target sequence database: /tmp/gapView.11706.genome.faa # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Query: TIGR01356 [M=415] Accession: TIGR01356 Description: aroA: 3-phosphoshikimate 1-carboxyvinyltransferase Scores for complete sequences (score includes all domains): --- full sequence --- --- best 1 domain --- -#dom- E-value score bias E-value score bias exp N Sequence Description ------- ------ ----- ------- ------ ----- ---- -- -------- ----------- 3.2e-144 466.7 0.0 3.6e-144 466.6 0.0 1.0 1 lcl|FitnessBrowser__SB2B:6937579 Sama_1734 3-phosphoshikimate 1-c Domain annotation for each sequence (and alignments): >> lcl|FitnessBrowser__SB2B:6937579 Sama_1734 3-phosphoshikimate 1-carboxyvinyltransferase (RefSeq) # score bias c-Evalue i-Evalue hmmfrom hmm to alifrom ali to envfrom env to acc --- ------ ----- --------- --------- ------- ------- ------- ------- ------- ------- ---- 1 ! 466.6 0.0 3.6e-144 3.6e-144 1 413 [. 14 425 .. 14 427 .. 0.95 Alignments for each domain: == domain 1 score: 466.6 bits; conditional E-value: 3.6e-144 TIGR01356 1 geikipgsKSishRalllaaLaegetvvtnlLkseDtlatlealrklGakve.ee.keelviegvgg.lkepe.ael 73 g ++ipgsKSis+Rallla La+get++ nlL+s+D++ +l+al++lG++++ ++ k +++ +g gg +++ + el lcl|FitnessBrowser__SB2B:6937579 14 GVVNIPGSKSISNRALLLATLASGETTLVNLLDSDDIRHMLNALKSLGVNFTlSDdKTVCTLNGLGGpIQTDKaFEL 90 679*************************************************744477888999999755555689* PP TIGR01356 74 dlgnsGttaRlltgvlalasgevvltgdeslkkRPierlveaLrelgaeieskeeegslPlaisgp.lkggivelsg 149 lgn+Gt++R+l ++l+l ge++ltg++++++RPi++lv+aLr+lga+i++ +++g++Pl+i+++ l gg+ve++g lcl|FitnessBrowser__SB2B:6937579 91 FLGNAGTAMRPLCAALTLGTGEFTLTGEPRMEERPIGDLVDALRQLGADIRYLKNDGFPPLTINATgLAGGVVEIDG 167 *****************999*********************************************98999******* PP TIGR01356 150 saSsQyksalllaaplalqavtleivgeklisrpyieitLkllksfgveveeederkivvkggqkykqk.evevegD 225 s SsQ+++all+ apla+ avt+ + g +l+s+pyi+itL+l+++fgv+v +++ +++ + gq+y ++ +v vegD lcl|FitnessBrowser__SB2B:6937579 168 SLSSQFLTALLMVAPLAKGAVTIAVKG-ELVSKPYIDITLDLMAKFGVTVVNDNYQRFEIASGQHYVSPgKVLVEGD 243 ******************999999988.*************************99**********76666******* PP TIGR01356 226 aSsAafflaaaaitgeevtvenlgenstqgdkaiiivLeemGadveveeqrdvevegasklkgvkvdidvdsliDel 302 aSsA++flaa+ai g+ev+v+++g qgd+++++ L +mGad+e+ e+ ++ +g skl+g++ +d+++++D++ lcl|FitnessBrowser__SB2B:6937579 244 ASSASYFLAAGAIGGGEVKVTGVGRLAVQGDVKFADALAAMGADIEWGED-YIIARG-SKLHGID--MDMNHIPDAA 316 **************************************************.588885.78*****..********** PP TIGR01356 303 ptlavlaafAegetriknieelRvkEsdRiaaiaeeLeklGveveeledgllieGkkkelkgavvdtydDHRiamal 379 +t+a++a+fAeg+tr+ ni ++R+kE+dR+aa+a+eL+k+G++vee++d+++i++ + a++dty+DHR+am++ lcl|FitnessBrowser__SB2B:6937579 317 MTIATAALFAEGTTRMSNIYNWRIKETDRLAAMATELRKVGAKVEEGHDYIQITPPV-KPVHAEIDTYNDHRMAMCF 392 ********************************************************6.5556*************** PP TIGR01356 380 avlglaaegeveiedaecvaksfPeFfevleqlg 413 ++l++a +v+i+d++c++k+fP++f+ ++l lcl|FitnessBrowser__SB2B:6937579 393 SLLAFADC-GVTINDPGCTSKTFPDYFNRFANLA 425 *****997.******************9988875 PP Internal pipeline statistics summary: ------------------------------------- Query model(s): 1 (415 nodes) Target sequences: 1 (428 residues searched) Passed MSV filter: 1 (1); expected 0.0 (0.02) Passed bias filter: 1 (1); expected 0.0 (0.02) Passed Vit filter: 1 (1); expected 0.0 (0.001) Passed Fwd filter: 1 (1); expected 0.0 (1e-05) Initial search space (Z): 1 [actual number of targets] Domain search space (domZ): 1 [number of targets reported over threshold] # CPU time: 0.01u 0.01s 00:00:00.02 Elapsed: 00:00:00.01 # Mc/sec: 10.79 // [ok]
This GapMind analysis is from Apr 09 2024. The underlying query database was built on Apr 09 2024.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory